The 1"Affiliated Hospital of Wenzhou Medical University
Welcome,         Profile    Billing    Logout  
 0 Trials 
4 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ma, Xiangyu
LBL-024-CN001, NCT05170958: A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors

Recruiting
1/2
396
RoW
LBL-024 for Injection, LBL-024
Nanjing Leads Biolabs Co.,Ltd
Advanced Solid Tumor
12/26
12/26
LBL-007-CN-004, NCT05516914: A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors

Recruiting
1/2
490
RoW
LBL-007 Injection, LBL-007, Tislelizumab Injection, Tislelizumab, Cisplatin Injection, Cisplatin, Gemcitabine Hydrochloride for Injection, Gemcitabine Hydrochloride, Docetaxel injection, Docetaxel
Nanjing Leads Biolabs Co.,Ltd
Malignant Tumors
10/25
12/25
NCT04640545: A Study to Assess LBL-007 in Combination With Toripalimab and Axitinib Tablets Subjects With Advanced Melanoma

Recruiting
1
88
RoW
LBL-007, Toripalimab, Axitinib Tablets
Nanjing Leads Biolabs Co.,Ltd
Advanced Melanoma
07/25
12/25
feng, ji
LBL-024-CN001, NCT05170958: A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors

Recruiting
1/2
396
RoW
LBL-024 for Injection, LBL-024
Nanjing Leads Biolabs Co.,Ltd
Advanced Solid Tumor
12/26
12/26

Download Options